Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2003
04/02/2003EP1296973A1 Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases
04/02/2003EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
04/02/2003EP1296959A1 Methods and compositions utilizing quinazolinones
04/02/2003EP1296949A2 Piperidine amides as modulators of chemokine receptor activity
04/02/2003EP1296678A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
04/02/2003EP1049690B1 s-(2'-HYDROXYPHENYL) BENZOTRIAZOLES CONTAINING A 2,4-IMIDAZOLIDINEDIONE GROUP AND PROCESS FOR THEIR PREPARATION
04/02/2003EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
04/02/2003EP0936218B1 Benzimidazole derivatives
04/02/2003EP0912512B1 Sulphonamide derivatives and their use in the treatment of cns disorders
04/02/2003EP0894089B9 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
04/02/2003EP0885189B9 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
04/02/2003EP0880504B1 Heterocyclo-substituted imidazoles for the treatment of inflammation
04/02/2003EP0587800B1 Immunomodulatory azaspiranes
04/02/2003CN1407973A Butyne diol derivatives
04/02/2003CN1406941A 1,2,4,5-pyromellitic anhydride preparation
04/02/2003CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides
04/02/2003CN1104419C Benzazepine derivatives with vasopressin agonistic activity
04/02/2003CN1104418C Benzoheterocyclic derivatives
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction
04/01/2003US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin.
04/01/2003US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/2003US6541499 Benzimidazole derivatives; e.g., 5-hydroxy-1-(3-methoxy-4-((1,2,4-triazol-1-yl)-methyl)benzyl) -2-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-benzimidazole
04/01/2003US6541486 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation.
04/01/2003US6541481 Substituted bicyclic derivatives useful as anticancer agents
04/01/2003US6541476 Piperazine derivatives and their use as anti-inflammatory agents
04/01/2003US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
04/01/2003US6541423 Controlling vegatation
03/2003
03/27/2003WO2003024969A1 Tyrosine kinase inhibitors
03/27/2003WO2003024956A1 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
03/27/2003WO2003024955A2 Small molecule inhibitors of caspases
03/27/2003WO2003024935A2 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003WO2003024926A2 Methods and compositions of novel triazine compounds
03/27/2003WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2003024401A2 Piperizinones as modulators of chemokine receptor activity
03/27/2003WO2003002553A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
03/27/2003WO2002101007A3 Antipathogenic benzamide compounds
03/27/2003WO2002060879A3 Bacterial gyrase inhibitors and uses thereof
03/27/2003WO2002032416A3 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
03/27/2003US20030060626 Fungicides
03/27/2003US20030060497 Use of indole Mannich bases in the production of medicaments that are used to treat pain
03/27/2003US20030060494 Dipeptidyl peptidase IV inhibiting agent; treatment of gastrointestinal disorders
03/27/2003US20030060471 Pyrazle derivative, production process thereof, and pest control agent containing the same as ative ingredient
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060453 Such as 4-((4-fluorophenyl)hydrazono)-4H-pyrazole- 3,5-diamine for antiproliferative activity, and promoting apoptosis in cells lacking normal regulation of cell cycle and death
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003US20030057826 1,4-diazepine derivatives useful as functional materials for use in organic electroluminescence devices
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2461074A1 Methods and compositions of novel triazine compounds
03/27/2003CA2460942A1 Substituted pyrazolyl compounds for the treatment of inflammation
03/26/2003WO2002026732A1 Benzodiazepine derivative
03/26/2003EP1295880A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
03/26/2003EP1295879A1 Medicinal compositions containing propenone derivatives
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1294922A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294713A2 Compounds possessing antibacterial, antifungal or antitumor activity
03/26/2003EP1294712A1 Process for the crystallization of losartan potassium
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294702A1 Benzodiazepine derivatives as app modulators
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294688A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1294376A2 Medicament for combating respiratory depression
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1159269B1 Anti-imflammatory indole derivatives
03/26/2003EP0863757B1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003EP0763026B1 Gastrin and cck antagonists
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406228A 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
03/26/2003CN1405157A Novel diazo alcoholic antifungal compound and its salt
03/26/2003CN1103772C Novel 2,3-disubstituted-4 (3H)-quinazolinone
03/26/2003CN1103770C Quino xaline diones
03/26/2003CN1103756C Estrogenic agents
03/26/2003CA2423902A1 Benzodiazepine derivative
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003US6538015 Anti-HIV pyrazole derivatives
03/25/2003US6537988 Synergistic methods and compositions for treating cancer
03/25/2003US6537948 Uracil compounds and use thereof
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/25/2003CA2254273C Preparation of substituted isoserine esters using metal alkoxides and .beta.-lactams
03/20/2003WO2003022832A1 Pyridylfurans and pyrroles as raf kinase inhibitors
03/20/2003WO2003022815A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
03/20/2003WO2003022808A1 Azetidin derivatives, method for their production and their use as pesticides
03/20/2003WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003WO2003022280A2 3-glyoxlylamideindoles for treating cancer
03/20/2003WO2003022274A2 2-aroylimidazole compounds for treating cancer
03/20/2003WO2003022272A1 Appetite-stimulating agents and remedies for anorexia
03/20/2003WO2003022055A1 Pesticidal compositions
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002085819A3 Production of tertiary amines by reductive amination
03/20/2003WO2002030886A3 Heterocyclic angiogenesis inhibitors
03/20/2003US20030055266 Small molecule modulators of G protein-coupled receptors
1 ... 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 ... 626